Abeona Therapeutics Inc. (NASDAQ: ABEO) started the day on January 04, 2022, with a price decrease of -5.86% at $0.35. During the day, the stock rose to $0.385 and sunk to $0.33 before settling in for the price of $0.37 at the close. Taking a more long-term approach, ABEO posted a 52-week range of $0.27-$3.79.
The Healthcare sector firm’s twelve-monthly sales growth has been 57.30% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -11.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 40.00%. This publicly-traded company’s shares outstanding now amounts to $97.99 million, simultaneously with a float of $86.02 million. The organization now has a market capitalization sitting at $33.69 million. At the time of writing, stock’s 50-day Moving Average stood at $0.6565, while the 200-day Moving Average is $1.2269.
It is quite necessary to find out the efficiency of the corporate organization, which has 76 number of employees on its payroll. It has generated 131,579 per worker during the last fiscal year. For the Profitability, stocks operating margin was -485.04 and Pretax Margin of -842.34.
Abeona Therapeutics Inc. (ABEO) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Abeona Therapeutics Inc.’s current insider ownership accounts for 1.50%, in contrast to 26.00% institutional ownership. According to the most recent insider trade that took place on Dec 06, this organization’s SVP, General Counsel sold 8,880 shares at the rate of 0.57, making the entire transaction reach 5,035 in total value, affecting insider ownership by 204,750. Preceding that transaction, on Nov 05, Company’s SVP, General Counsel sold 8,880 for 0.89, making the whole transaction’s value amount to 7,894. This particular insider is now the holder of 213,630 in total.
Abeona Therapeutics Inc. (ABEO) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2021, the organization reported -$0.07 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.16) by $0.09. This company achieved a net margin of -842.34 while generating a return on equity of -59.96. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
Abeona Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 40.00% and is forecasted to reach -0.49 in the upcoming year.
Abeona Therapeutics Inc. (NASDAQ: ABEO) Trading Performance Indicators
Let’s observe the current performance indicators for Abeona Therapeutics Inc. (ABEO). It’s Quick Ratio in the last reported quarter now stands at 2.60. The Stock has managed to achieve an average true range (ATR) of 0.05. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 11.23.
In the same vein, ABEO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.57, a figure that is expected to reach -0.12 in the next quarter, and analysts are predicting that it will be -0.49 at the market close of one year from today.
Technical Analysis of Abeona Therapeutics Inc. (ABEO)
If we take a close look at the recent performances of Abeona Therapeutics Inc. (NASDAQ: ABEO), its last 5-days Average volume was 4.71 million that shows progress from its year to date volume of 4.46 million. During the previous 9 days, stock’s Stochastic %D was recorded 71.60% While, its Average True Range was 0.0502.
Raw Stochastic average of Abeona Therapeutics Inc. (ABEO) in the period of the previous 100 days is set at 7.18%, which indicates a major fall in contrast to 27.96% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 239.08% that was higher than 113.33% volatility it exhibited in the past 100-days period.